Article Information
History
- October 28, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Cheng Chen, PhD1,
- Michael P. Douglas, MS1,
- Meera V. Ragavan, MD, MPH2,
- Kathryn A. Phillips, PhD1,3,4 and
- Jeroen P. Jansen, PhD1,3,4,*
- 1Department of Clinical Pharmacy, UCSF Center for Translational and Policy Research on Precision Medicine (TRANSPERS), San Francisco, California
- 2Division of Hematology and Oncology, UCSF Department of Medicine, San Francisco, California
- 3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
- 4UCSF Philip R. Lee Institute for Health Policy, San Francisco, California
- ↵*Corresponding Author:
Jeroen Jansen, Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 490 Illinois St. Valley Tower, 3rd Floor, Box 0613, San Francisco, CA 94143 (jeroen.jansen{at}ucsf.edu)